Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Leverkus

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The British Journal of Dermatology|February 1, 2011
Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VIIM Leverkus, A Ambach, M Hoefeld-Fegeler, et al.
Cancer Research|February 17, 2000
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytesM Leverkus, M Neumann, T Mengling, et al.
Cell Death & Disease|October 10, 2014
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosisI Karl, M Jossberger-Werner, N Schmidt, et al.
European Journal of Immunology|September 29, 2000
MHC class II and CD40 play opposing roles in dendritic cell survivalA McLellan, M Heldmann, G Terbeck, et al.
The Journal of Investigative Dermatology|January 29, 2000
Thymidine dinucleotides inhibit contact hypersensitivity and activate the gene for tumor necrosis factor alpha1P D Cruz, M Leverkus, I Dougherty, et al.
Cell Death & Disease|September 11, 2015
Absence of RIPK3 predicts necroptosis resistance in malignant melanomaP Geserick, J Wang, R Schilling, et al.
Oncogene|January 11, 2011
Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradationM Neumann, S Klar, A Wilisch-Neumann, et al.
Cell Death and Differentiation|March 30, 2001
Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell developmentA D McLellan, G Terbeck, T Mengling, et al.
The British Journal of Dermatology|March 20, 2002
Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230M Leverkus, K Bhol, Y Hirako, et al.
Oncogene|December 18, 2007
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosisP Geserick, C Drewniok, M Hupe, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The British Journal of Dermatology|February 1, 2011
Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VIIM Leverkus, A Ambach, M Hoefeld-Fegeler, et al.
Cancer Research|February 17, 2000
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytesM Leverkus, M Neumann, T Mengling, et al.
Cell Death & Disease|October 10, 2014
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosisI Karl, M Jossberger-Werner, N Schmidt, et al.
European Journal of Immunology|September 29, 2000
MHC class II and CD40 play opposing roles in dendritic cell survivalA McLellan, M Heldmann, G Terbeck, et al.
The Journal of Investigative Dermatology|January 29, 2000
Thymidine dinucleotides inhibit contact hypersensitivity and activate the gene for tumor necrosis factor alpha1P D Cruz, M Leverkus, I Dougherty, et al.
Cell Death & Disease|September 11, 2015
Absence of RIPK3 predicts necroptosis resistance in malignant melanomaP Geserick, J Wang, R Schilling, et al.
Oncogene|January 11, 2011
Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradationM Neumann, S Klar, A Wilisch-Neumann, et al.
Cell Death and Differentiation|March 30, 2001
Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell developmentA D McLellan, G Terbeck, T Mengling, et al.
The British Journal of Dermatology|March 20, 2002
Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230M Leverkus, K Bhol, Y Hirako, et al.
Oncogene|December 18, 2007
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosisP Geserick, C Drewniok, M Hupe, et al.
Pageof 4